Mitsubishi UFJ Asset Management Co. Ltd. Grows Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 7.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,586,022 shares of the real estate investment trust’s stock after acquiring an additional 105,720 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.23% of Healthpeak Properties worth $32,387,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. raised its position in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the period. M&T Bank Corp purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $22,995,000. HighTower Advisors LLC acquired a new position in Healthpeak Properties during the 3rd quarter worth approximately $4,141,000. Diamant Asset Management Inc. acquired a new position in Healthpeak Properties during the 3rd quarter worth approximately $564,000. Finally, Public Employees Retirement System of Ohio purchased a new position in Healthpeak Properties in the 3rd quarter worth approximately $29,226,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on DOC shares. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research report on Wednesday, January 15th. StockNews.com raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, March 22nd. Wells Fargo & Company lowered their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Wedbush cut their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Finally, Robert W. Baird lowered their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $23.92.

Healthpeak Properties Stock Performance

DOC stock opened at $20.20 on Friday. The firm has a market cap of $14.13 billion, a P/E ratio of 57.70, a P/E/G ratio of 2.17 and a beta of 1.14. The stock’s 50 day simple moving average is $20.23 and its 200 day simple moving average is $21.10. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12-month low of $17.80 and a 12-month high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were given a $0.305 dividend. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.04%. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.